Sumitomo Pharma Co. Ltd.

In News

Sumitomo Pharma’s iPS Cell Parkinson’s Therapy Heads to Key Japan Regulatory Review - TipRanks

TipRanks - Feb 13, 2026

Sumitomo Pharma Co. (DNPUF) Price Target Increased by 39.32% to 13.38 - Nasdaq

Nasdaq - Feb 03, 2026

Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis - PR Newswire

PR Newswire - Jul 30, 2025

Investors Shouldn't Be Too Comfortable With Sumitomo Pharma's (TSE:4506) Earnings - simplywall.st

simplywall.st - Feb 06, 2026

Establishment of a Pharmaceutical Strategic Platform： Succession of Sumitomo Pharma’s Business in Asia - marubeni.com

marubeni.com - Apr 01, 2025

Earnings call transcript: Sumitomo Dainippon Pharma beats Q3 2025 expectations - Investing.com

Investing.com - Feb 06, 2026

Will FTSE All-World Index Inclusion Boost Global Attention on Sumitomo Pharma's (TSE:4506) Narrative? - Yahoo Finance

Yahoo Finance - Sep 22, 2025

Knight Therapeutics and Sumitomo Pharma enter into - GlobeNewswire

GlobeNewswire - Jun 05, 2025

Sumitomo’s DSP-3456 exerts antidepressant-like effects - bioworld.com

bioworld.com - Jan 16, 2026

Optimistic Investors Push Sumitomo Pharma Co., Ltd. (TSE:4506) Shares Up 26% But Growth Is Lacking - simplywall.st

simplywall.st - Jan 10, 2026

Sumitomo Pharma Q3 FY2025 slides: North American sales drive 408% profit surge - Investing.com Nigeria

Investing.com Nigeria - Feb 07, 2026

Sumitomo Pharma America Presents New Data on Vibegron at the 2025 American Urological Association Annual Meeting - PR Newswire

PR Newswire - Apr 29, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment